The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Bacillus coagulans: a viable adjunct therapy for relieving symptoms of rheumatoid arthritis according to a randomized, controlled trial
Open accessAbstract
BACKGROUND: Lactic acid-producing bacteria (LAB) probiotics demonstrate immunomodulating and anti-inflammatory effects and the ability to lessen the symptoms of arthritis in both animals and humans. This randomized, double-blind, placebo-controlled, parallel-design, clinical pilot trial was conducted to evaluate the effects of the LAB probiotic preparation, Bacillus coagulans GBI-30, 6086, on symptoms and measures of functional capacity in patients with rheumatoid arthritis (RA) in combination with pharmacological anti-arthritic medications. METHODS: Forty-five adult men and women with symptoms of RA were randomly assigned to receive Bacillus coagulans GBI-30, 6086 or placebo once a day in a double-blind fashion for 60 days in addition to their standard anti-arthritic medications. Arthritis activity was evaluated by clinical examination, the American College of Rheumatology (ACR) criteria, the Stanford Health Assessment Questionnaire Disability Index (HAQ-DI), and laboratory tests for erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP). RESULTS: Subjects who received Bacillus coagulans GBI-30, 6086 experienced borderline statistically significant improvement in the Patient Pain Assessment score (P = .052) and statistically significant improvement in Pain Scale (P = .046) vs placebo. Compared with placebo, Bacillus coagulans GBI-30, 6086 treatment resulted in greater improvement in patient global assessment and self-assessed disability; reduction in CRP; as well as the ability to walk 2 miles, reach, and participate in daily activities. There were no treatment-related adverse events reported throughout this study. CONCLUSIONS: Results of this pilot study suggest that adjunctive treatment with Bacillus coagulans GBI-30, 6086 LAB probiotic appeared to be a safe and effective for patients suffering from RA. Because of the low study population size, larger trials are needed to verify these results. TRIAL REGISTRATION: ACTRN12609000435280.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lawrence, R. C., Felson, D. T., Helmick, C. G., Arnold, L. M., Choi, H., Deyo, R. A., Gabriel, S., Hirsch, R., Hochberg, M. C., Hunder, G. G., et al. (2008) · Arthritis & Rheumatism · doi:10.1002/art.23176 · Cited by 5,499
American college of rheumatology preliminary definition of improvement in rheumatoid arthritis
Felson, D. T., Anderson, J. J., Boers, M., Bombardier, C., Furst, D., Goldsmith, C., Katz, L. M., Lightfoot, R., Paulus, H., Strand, V., et al. (1995) · Arthritis & Rheumatism · doi:10.1002/art.1780380602 · Cited by 2,829
Estimates of the prevalence of arthritis and other rheumatic conditions in the United States: Part I
Helmick, C. G., Felson, D. T., Lawrence, R. C., Gabriel, S., Hirsch, R., Kwoh, C. K., Liang, M. H., Kremers, H. M., Mayes, M. D., Merkel, P. A., et al. (2008) · Arthritis & Rheumatism · doi:10.1002/art.23177 · Cited by 2,058
Therapeutic strategies for rheumatoid arthritis
Smolen, J. S., & Steiner, G. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1109 · Cited by 911
Tlaskalová-Hogenová, H., Štěpánková, R., Hudcovic, T., Tučková, L., Cukrowska, B., Lodinová-Žádnı́ková, R., Kozáková, H., Rossmann, P., Bártová, J., Sokol, D., et al. (2004) · Immunology Letters · doi:10.1016/j.imlet.2004.02.005 · Cited by 755
Health assessment questionnaire (HAQ)
(2009) · Dictionary of Rheumatology · doi:10.1007/978-3-211-79280-3_429 · Cited by 693
Quality assurance criteria for probiotic bacteria
Tuomola, E., Crittenden, R., Playne, M., Isolauri, E., & Salminen, S. (2001) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/73.2.393s · Cited by 432
Towards understanding molecular modes of probiotic action
Marco, M. L., Pavan, S., & Kleerebezem, M. (2006) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2006.02.005 · Cited by 346
Bacillus Probiotics: Spore Germination in the Gastrointestinal Tract
Casula, G., & Cutting, S. M. (2002) · Applied and Environmental Microbiology · doi:10.1128/aem.68.5.2344-2352.2002 · Cited by 336
Acid and bile tolerance of spore-forming lactic acid bacteria
Hyronimus, B., Le Marrec, C., Hadj Sassi, A., & Deschamps, A. (2000) · International Journal of Food Microbiology · doi:10.1016/s0168-1605(00)00366-4 · Cited by 321
Cited by
Cutting, S. M. (2011) · Food Microbiology · doi:10.1016/j.fm.2010.03.007 · Cited by 787
The microbiome in autoimmune diseases
De Luca, F., & Shoenfeld, Y. (2018) · Clinical and Experimental Immunology · doi:10.1111/cei.13158 · Cited by 510
Sivakumar, D., & Bautista-Baños, S. (2014) · Crop Protection · doi:10.1016/j.cropro.2014.05.012 · Cited by 448
Bacillus strains as human probiotics: characterization, safety, microbiome, and probiotic carrier
Lee, N.-K., Kim, W.-S., & Paik, H.-D. (2019) · Food Science and Biotechnology · doi:10.1007/s10068-019-00691-9 · Cited by 382
Probiotic supplementation improves inflammatory status in patients with rheumatoid arthritis
Vaghef-Mehrabany, E., Alipour, B., Homayouni-Rad, A., Sharif, S.-K., Asghari-Jafarabadi, M., & Zavvari, S. (2014) · Nutrition · doi:10.1016/j.nut.2013.09.007 · Cited by 311
Metadata
- Authors
- Mandel, D. R., Eichas, K., & Holmes, J.
- Venue
- BMC Complementary and Alternative Medicine
- Published
- 2010-01-12
- Volume
- 10
- Issue
- 1
- Pages
- 1-1
- ISSN
- 1472-6882 (ISSN-L)
- OpenAlex
- W2122839875
- Cited by
- 406
- References
- 29
- FWCI
- 29.80
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Bacillus coagulans: a viable adjunct therapy for relieving symptoms of rheumatoid arthritis according to a randomized, controlled trial. https://app.cochat.ai/papers/10.1186/1472-6882-10-1
- The paper
- Mandel, D. R., Eichas, K., & Holmes, J. (2010). Bacillus coagulans: a viable adjunct therapy for relieving symptoms of rheumatoid arthritis according to a randomized, controlled trial. BMC Complementary and Alternative Medicine. https://doi.org/10.1186/1472-6882-10-1
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.